Subsequently, we analyzed the correlations of CCL18 expression levels with selected clinicopathological features of ESCC patients (Table 1) and found that CCL18 was significantly correlated with tumor stage (P = 0.0001). The gene discussed is CCL18; the disease is neoplasm.